Diagnostic utility of pleural fluid/serum bilirubin ratio versus light’s criteria in differentiating exudative and transudative pleural effusions. A cross-sectional observational study.
DOI:
https://doi.org/10.51168/sjhrafrica.v6i9.2154Keywords:
Pleural effusion, Exudates, Transudates, Light’s criteria, Bilirubin ratioAbstract
Background
Differentiation between exudative and transudative pleural effusions is fundamental for guiding clinical management. Light’s criteria remain the standard, though reports suggest misclassification in certain cases, necessitating exploration of alternative biochemical markers.
Objectives
To evaluate the efficacy of the pleural fluid/serum bilirubin ratio in differentiating exudative from transudative pleural effusions in comparison with Light’s criteria.
Methods
A cross-sectional observational study was conducted on 60 patients with pleural effusion at a tertiary care center from January 2021 to June 2022. Patients underwent detailed clinical evaluation, radiological assessment, and biochemical analysis of pleural fluid and serum for protein, lactate dehydrogenase (LDH), and bilirubin. Ratios of pleural fluid to serum concentrations were calculated. Exudates and transudates were classified using clinical criteria, and diagnostic performance of Light’s criteria and bilirubin ratio was compared.
Results
Of the 60 patients, 33 (55%) had exudative and 27 (45%) transudative effusions. Exudates were more common in males (57.5%) and in the age group 31–50 years, whereas transudates predominated among females and those aged 51–70 years. Tuberculosis (48.5%) and malignancy (36.4%) were the leading causes of exudates, while congestive cardiac failure (44.5%) and chronic liver disease (37%) were the main transudative etiologies. The mean pleural fluid/serum bilirubin ratio (0.74 vs. 0.32, p < 0.001) significantly differentiated exudates from transudates. Diagnostic accuracy was highest for the bilirubin ratio (96.67%) compared to Light’s criteria (95%), with superior specificity in identifying transudates.
Conclusion
The pleural fluid/serum bilirubin ratio is a simple, cost-effective, and reliable parameter, with diagnostic accuracy comparable to Light’s criteria.
Recommendations
The bilirubin ratio can be used as an adjunct or alternative to Light’s criteria, especially in resource-limited settings, to minimize misclassification. Larger multicentric studies are recommended to validate its clinical utility and establish standardized cut-off values.
References
Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med. 1972 Oct;77(4):507-13. doi: 10.7326/0003-4819-77-4-507. PMID: 4642731.
Agrawal P, Shrestha TM, Prasad PN, Aacharya RP, Gupta P. Pleural Fluid Serum Bilirubin Ratio for Differentiating Exudative and Transudative Effusions. JNMA J Nepal Med Assoc. 2018 Mar-Apr;56(211):662-665. PMID: 30381760; PMCID: PMC8997272.
Meisel S, Shamiss A, Thaler M, Nussinovitch N, Rosenthal T. Pleural fluid to serum bilirubin concentration ratio for the separation of transudates from exudates. Chest. 1990 Jul;98(1):141-4. doi: 10.1378/chest.98.1.141. PMID: 2361381.
Metintaş M, Alataş O, Alataş F, Colak O, Ozdemir N, Erginel S. Comparative analysis of biochemical parameters for differentiation of pleural exudates from transudates Light's criteria, cholesterol, bilirubin, albumin gradient, alkaline phosphatase, creatine kinase, and uric acid. Clin Chim Acta. 1997 Aug 29;264(2):149-62. doi: 10.1016/s0009-8981(97)00091-0. PMID: 9293374.
Bielsa S, Porcel JM, Castellote J, Mas E, Esquerda A, Light RW. Solving the Light's criteria misclassification rate of cardiac and hepatic transudates. Respirology. 2012 May;17(4):721-6. doi: 10.1111/j.1440-1843.2012.02155.x. PMID: 22372660.
Agrawal P, Shrestha TM, Prasad PN, Aacharya RP, Gupta P. Pleural Fluid Serum Bilirubin Ratio for Differentiating Exudative and Transudative Effusions. JNMA J Nepal Med Assoc. 2018 Mar-Apr;56(211):662-665. PMID: 30381760; PMCID: PMC8997272.
Gautam S, K C SR, Bhattarai B, K C G, Adhikari G, Gyawali P, et al. Diagnostic value of pleural cholesterol in differentiating exudative and transudative pleural effusion. Ann Med Surg (Lond). 2022 Sep 5;82:104479. doi: 10.1016/j.amsu.2022.104479. PMID: 36268319; PMCID: PMC9577431.
Burgess LJ. Biochemical analysis of pleural, peritoneal and pericardial effusions. Clin Chim Acta. 2004 May;343(1-2):61-84. doi: 10.1016/j.cccn.2004.02.002. PMID: 15115678.
Karkhanis VS, Joshi JM. Pleural effusion: diagnosis, treatment, and management. Open Access Emerg Med. 2012 Jun 22;4:31-52. doi: 10.2147/OAEM.S29942. PMID: 27147861; PMCID: PMC4753987.
Heffner JE. Discriminating between transudates and exudates. Clin Chest Med. 2006 Jun;27(2):241-52. doi: 10.1016/j.ccm.2005.12.008. PMID: 16716816.
Mohan G, Bhide P, Agrawal A, Kaul V, Chaddha U. A practical approach to pseudoexudative pleural effusions. Respir Med. 2023 Aug;214:107279. doi: 10.1016/j.rmed.2023.107279. Epub 2023 May 10. PMID: 37172787.
Vaz MA, Teixeira LR, Vargas FS, Carmo AO, Antonangelo L, Onishi R, et al. Relationship between pleural fluid and serum cholesterol levels. Chest. 2001 Jan;119(1):204-10. doi: 10.1378/chest.119.1.204. PMID: 11157605.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jonnalagadda Monika , Dr. S Deepan Raj, Dr. Beera Nithin Joseph , Dr.Perapagu Jhansi

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
















